0 NASDAQ Companies - September 20, 2024Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)SOUTH SAN FRANCISCO, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a […]Read More
0 NASDAQ Companies - September 20, 2024Gaxos.ai Inc. Announces Exercise of Warrants for $3.24 Million Gross ProceedsRoseland, NJ, Sept. 20, 2024 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial […]Read More
0 NASDAQ Companies - September 20, 2024Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity – Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health […]Read More
0 TSX News - September 20, 2024DIRTT Announces Results of Special Meeting of ShareholdersCALGARY, Alberta, Sept. 20, 2024 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT”) (TSX: DRT) (OTC: DRTTF) announced today the […]Read More
0 NYSE Companies - September 20, 2024Minerals Technologies Announces Participation in Gabelli Funds 2nd Annual PFAS SymposiumNEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) — Minerals Technologies Inc. (NYSE: MTX) announced participation in Gabelli Funds PFAS Symposium in […]Read More
0 TSX Venture News - September 20, 2024LEADING EDGE REPORTS QUARTERLY RESULTS TO JULY 31, 2024LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2024 Vancouver, September 20, 2024– Leading Edge Materials Corp. (“Leading Edge […]Read More
0 TSX News - September 20, 2024Century Announces Results of 2024 Shareholder MeetingTHIS NEWS RELEASE IS NOT FOR DISTRIBUTIONIN THE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, Sept. 20, 2024 […]Read More
0 NASDAQ Companies - September 20, 2024Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type CMIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive neurodegenerative disease MIPLYFFA is […]Read More
0 NASDAQ Companies - September 20, 2024TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) — TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC […]Read More
0 TSX Venture News - September 20, 2024Giga Metals to Present at Noble Capital Markets’ Basic Industries Emerging Growth Virtual Equity Conference September 25th 2024VANCOUVER, British Columbia, Sept. 20, 2024 (GLOBE NEWSWIRE) — Giga Metals Corporation (TSX.V: GIGA, OTCQX: GIGGF), a junior mining company […]Read More